Australian government funds $1M for development of Vaxine’s Covax-19® vaccine

The pioneering team at Vaxine who developed the world’s first swine flu vaccine in 2009, has been awarded funding of $1 million dollars from the Biomedical Translation Bridge (BTB) program, an initiative of the Medical Research Future Fund operated by MTPConnect, to help advance Vaxine’s state-of-the-art COVID-19 vaccine candidate called Covax-19®. Sharen Pringle, Vaxine’s Business […]

The first Covid-19 vaccine developed in the Southern hemisphere enters Phase 1 human trials in Adelaide

The first Australian-developed candidate to reach human trials, Vaxine began a Phase I trial in early July in Adelaide. The trial will test 40 healthy candidates and results are expected in six to eight weeks, according to the Australian Financial Review. “From there we will look to commence phase II and III trials straight away,” […]

Sypharma partners with Vaxine Pty Ltd. to manufacture COVID-19 vaccine product

“This is the 16th vaccine to enter trials globally but is the first COVID-19 vaccine developed in the Southern hemisphere to enter human trials, and the first COVID-19 vaccine designed with the help of AI,” said Professor Nikolai Petrovsky. Sypharma has a long-standing relationship with Vaxine with over a decade of manufacturing Advax delta inulin adjuvant, […]

Flinders University scientists led by Tasmanian Professor Nik Petrovsky on track to have a vaccine by the end of the year

The first COVID-19 vaccine to be developed in the southern hemisphere has progressed to human trials. But the company behind it is funded by the United States’ National Institute of Allergy and Infectious Diseases, so will it stay in Australia? Duration: 17min 40sec Broadcast: Fri 3 Jul 2020, 8:30am link to the podcast

Vaxine Pty Ltd announces COVID-19 vaccine collaboration with Kazakh National Agrarian University

Vaxine executes COVID-19 vaccine memorandum of understanding with theInternational Centre for Vaccinology at the Kazakh National Agrarian University. “Pandemic viruses do not respect national borders and consequently, it is vitally important that scientists from all countries openly work together in a collaborative fashion to counter such global threats”, said Professor Nikolai Petrovsky MBBS, FRACP, Ph.D., […]

Vaxine and University of Georgia Complete First Stage of COVID-19 Ferret Challenge Studies

COVAX-19® immunizations completed at University of Georgia to assess COVID-19 protection. Vaxine Pty Ltd announced today completion of the immunization phase of ferret challenge studies being conducted at the University of Georgia to test the ability of Vaxine’s promising COVAX-19® vaccine to protect against COVID-19. “We have already seen that COVAX-19® vaccine induces potent antibody […]

Pharma research firm APC partners to develop Covid-19 vaccine with Vaxine

Irish company working with Australian vaccine developer Vaxine on a new candidate Irish pharmaceutical research company APC has partnered with an Australian biotech firm to accelerate the development and launch of a vaccine for coronavirus. The pharmaceutical research company, which designs, develops, and markets proprietary engineering platform technologies that reduce the time, cost, and risk […]

Flinders targets COVID-19 vaccine

South Australian researchers working with Oracle Cloud technology and vaccine technology developed by local company Vaxine Pty Ltd are testing a vaccine candidate against the SARS-CoV-2 coronavirus responsible for the COVID-19 pandemic. The team is headed by Nikolai Petrovsky, Flinders University Professor and Research Director at Vaxine.